It just shows the importance of level headed valuation of deals...

It just shows the importance of level headed valuation of deals not getting things blown out of propotion on hype BLT reached the licensing agreement with Pfizer the only up-front was assistance with development costs with potential milestones of $150M - something that is drawn out over time but when latching hype it's easy for people to assume that it has a guaranteed value to the company of $150M. The share price went balistic taking the company from $30M to $100M of which barely held for the day by the next week it was back with it's $30M share price.

It's just about finding balance - if you want the roulette wheel though hype always delivers dollars for those that trade it right - often scars a company across the market for a while & something not easily forgotten with the chart always holding the evidence.

I do hear what you'r saying in regards to the legal aspects as what brought it back to 2c but just making the point that the Pfizer hype spike didn't last long & was more a case of trader push than validated push - there's been a few others too great deals big sums but "not yet".